Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Robert Barry
AddedMar 31, 2024
UpdatedMay 31, 2026
Robert Barry

Robert Barry

Co-Founder, Stasys

CrunchbaseLinkedIn

Robert Barry's Career

Stasys
Stasys

Huntersville, NC, US

Co-Founder
Opticyte
Opticyte

Seattle, WA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Robert Barry's Career

Stasys
Stasys
Pre-Seed$2.6M62013Huntersville, NC, US
Co-Founder

Leadership at Stasys

Nathan WhiteNathan WhiteCo-Founder
Nate SniadeckiNate SniadeckiCo-Founder

Similar to Stasys

St. Teresa MedicalSt. Teresa MedicalSaint Paul, MN, USMedical Devicesest. 2010St. Teresa MedicalSaint Paul, MN, US · est. 2010

St. Teresa Medical, Inc.: Innovating hemostatic technology for effective treatment of severe bleeding.

Seed · $11.8M5
CloSysCloSysMinneapolis, MN, USHemostatic Devicesest. 2005CloSysMinneapolis, MN, US · est. 2005

CloSys Corp: Innovating healthcare with rapid vascular closure devices for anticoagulated patients.

Public · $2.4M7
LevisonicsLevisonicsFishers, IN, USMedical Devicesest. 2016LevisonicsFishers, IN, US · est. 2016

Levisonics: Innovating non-contact blood analysis devices for precise haemostatic assays.

Pre-Seed · $1.4M5
Coagulo Medical TechnologiesCoagulo Medical TechnologiesAuburndale, MA, USDiagnostics, Medical Devicesest. 2018Coagulo Medical TechnologiesAuburndale, MA, US · est. 2018

Coagulo Medical Technologies: Revolutionizing medicine with a portable, connected precision-medicine platform.

Series A · $6.8M9
Opticyte
Opticyte
Series A$5.7M82016Seattle, WA, US
Board Member· Board

Leadership at Opticyte

Lori ArakakiLori ArakakiCEO
Kenneth SchenkmanKenneth SchenkmanFounder

Similar to Opticyte

ViOptixViOptixFremont, CA, USTissue Oximetryest. 1999ViOptixFremont, CA, US · est. 1999

US-based ViOptix innovates in biotech, creating proprietary tissue oximetry products.

Seed · $27.2M14
NoninvasixNoninvasixGalveston, TX, USMedical Devicesest. 2007NoninvasixGalveston, TX, US · est. 2007

Noninvasix, Inc. offers safe, accurate, non-invasive neonatal monitoring solutions in the US.

Seed · $7.4M4
Opticent HealthOpticent HealthEvanston, IL, USMedical Devicesest. 2015Opticent HealthEvanston, IL, US · est. 2015

Opticent Health: A medical device startup innovating ophthalmic diagnostic and imaging technology.

Angel · $224.8k7
Bioxytech RetinaBioxytech RetinaRichmond, CA, USMedical Devicesest. 2015Bioxytech RetinaRichmond, CA, US · est. 2015

Bioxytech Retina, founded in 2015, pioneers non-invasive optical devices for diabetes diagnosis.

Pre-Seed · $1.2M5

Robert Barry's Similar Executives & Operators

Nugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance Retail

People Similar to Robert Barry

Mark BarrishMark BarrishCo-Founder · Moray MedicalMurtaza HussainMurtaza HussainFounder · pledges.comMichael HuffordMichael HuffordCo-Founder · e-Nicotine TechnologyAlan LucasAlan LucasFounder & CEO · Navigation SciencesBert RubinskyBert RubinskyCo-Founder · Medical Grade InnovationsJeff McLarenJeff McLarenBoard Member · HealthStream